Amarenco P,Boqousslavsky J,Callahan A,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].New Engl J Med,2006,355(6):549-559.
[5]
Kadikoylu G,Uysal HB,Yenisey C,et al.The effects of atorvastatin on hematological and inflammatory parameters[J].Blood,2008,112(11):1548.
[6]
Kitamura A,Iso H,Imano H,et al.Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderlymen[J].Stroke,2004,35(12):2788-2794.
[7]
Clunn GF,Sever PS,Hughes AD.Calcium channel regulation in vascular smooth muscle cells:Synergistic effects of statins and calcium channel blockers[J].Int J Cardiol, 2010,139(1):2-6.
[8]
Luan Z,Chase AJ,Newby AC.Statins inhibit secretion of metalloproteinases-1,-2,-3,and -9 from vascular smooth muscle cells and macrophages[J].Arterioscler Thromb Vasc Biol,2003,23(5):769-775.
[9]
Matsumura M,Fukuda N,Kobayashi N,et al.effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats[J].J Atheroscler Thromb,2009,16(4):319-326.
[10]
Lampl Y,Lorberboym M,Gilad R,et al.Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin[J].Clin Neurophar-macol,2010,33(3):129-134.
[11]
Csaszar A.Important aim of statin therapy:ischemic cardiovascular event(stroke)[J].Ideggyogy Sz,2008,61(7-8):239-243.
[12]
Sillesen H,Amarenco P,Hennerici MG,et al.Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis[J].Stroke,2008, 39(12):3297-3302.
[13]
Huisa BN,Stemer AB,Zivin JA.Atorvastatin in stroke: a review of SPARCL and subgroup analysis[J].Vasc Health Risk Manag,2010,6(4):229-236.
[14]
Paciaroni M,Bogousslavsky J.Statins and stroke prevention[J].Expert Rev Cardiovasc Ther,2009,7(10):1231-1243.
[15]
Idicula TT,Brogger J,Naess H,et al.Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality:The Bergen stroke study[J].BMC Neurol,2009,9(1):18.
